No tumors were detected in the ovaries, oviduct and uterine-AdCre injected mice carrying mutations in either Kras alone (MK mice) or Pten alone (MP mice, data not shown), suggesting that, as with ovarian tumors [26], both pathways need to be active in order for tumors to occur. Here, KRAS is linked to ovarian neoplasm.